Triazol compounds for treating biofilm formation

Details for Australian Patent Application No. 2012201134 (hide)

Owner Novartis AG

Inventors Reid, David

Agent Davies Collison Cave

Pub. Number AU-A-2012201134

Parent 2008252964

Filing date 27 February 2012

Wipo publication date 22 March 2012

International Classifications

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

15 March 2012 Complete Application Filed

22 March 2012 Application Open to Public Inspection

  Published as AU-A-2012201134

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201135-An amphibious vehicle

2012201133-Liquefaction of associated gas at moderate conditions